L-天冬酰胺酶：对肿瘤疾病患者的治疗作用及毒性作用 - Suppr

Suppr

超能文献

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.

作者信息

Haskell C M, Canellos G P, Leventhal B G, Carbone P P, Block J B, Serpick A A, Selawry O S

出版信息

N Engl J Med. 1969 Nov 6;281(19):1028-34. doi: 10.1056/NEJM196911062811902.

DOI:10.1056/NEJM196911062811902

PMID:4898857

Abstract

摘要

相似文献

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.

N Engl J Med. 1969 Nov 6;281(19):1028-34. doi: 10.1056/NEJM196911062811902.

Clinical experience with L-asparaginase.

Recent Results Cancer Res. 1970;33:236-43. doi: 10.1007/978-3-642-99984-0_28.

Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.

J Pediatr. 1970 Sep;77(3):474-83. doi: 10.1016/s0022-3476(70)80023-3.

[Asparaginase, leukemia and cancer].

Bull Cancer. 1969 Oct-Dec;56(4):365-74.

Clinical experience with L-asparaginase.

Recent Results Cancer Res. 1970;33:257-62. doi: 10.1007/978-3-642-99984-0_30.

The clinical toxicities of L-asparaginase in treatment of leukemia and lymphoma.

Pediatrics. 1970 Apr;45(4):555-9.

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.

Cancer. 1970 Feb;25(2):279-305. doi: 10.1002/1097-0142(197002)25:2<279::aid-cncr2820250205>3.0.co;2-7.

Treatment of acute leukemia with L-asparaginase.

Recent Results Cancer Res. 1970;33:204-18. doi: 10.1007/978-3-642-99984-0_26.

Some clinical observations on the treatment with L-asparaginase of the acute leukemias.

Recent Results Cancer Res. 1970;33:296-315. doi: 10.1007/978-3-642-99984-0_34.

Adverse reactions of L-asparaginase.

Am J Pediatr Hematol Oncol. 1982 Fall;4(3):335-9.

引用本文的文献

Repurposing Asparaginase Therapy to Target Cisplatin-Resistant Cancer Cells.

Fundam Clin Pharmacol. 2025 Oct;39(5):e70044. doi: 10.1111/fcp.70044.

Exploring the potential of asparagine restriction in solid cancer treatment: recent discoveries, therapeutic implications, and challenges.

Med Oncol. 2024 Jun 15;41(7):176. doi: 10.1007/s12032-024-02424-3.

Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia.

Cancer Cell. 2024 Apr 8;42(4):552-567.e6. doi: 10.1016/j.ccell.2024.03.003.

Recent advances in glucose oxidase-based nanocarriers for tumor targeting therapy.

Heliyon. 2023 Sep 25;9(10):e20407. doi: 10.1016/j.heliyon.2023.e20407. eCollection 2023 Oct.

Amino acid metabolism in health and disease.

Signal Transduct Target Ther. 2023 Sep 13;8(1):345. doi: 10.1038/s41392-023-01569-3.

Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunity.

Blood. 2023 May 25;141(21):2553-2565. doi: 10.1182/blood.2022018258.

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy.

Blood Lymphat Cancer. 2022 May 30;12:55-79. doi: 10.2147/BLCTT.S342052. eCollection 2022.

The past, present, and future of enzyme-based therapies.

Drug Discov Today. 2022 Jan;27(1):117-133. doi: 10.1016/j.drudis.2021.09.004. Epub 2021 Sep 16.

Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.

Paediatr Drugs. 2021 Sep;23(5):457-463. doi: 10.1007/s40272-021-00463-1. Epub 2021 Aug 5.

Dietary intervention as a therapeutic for cancer.

Cancer Sci. 2021 Feb;112(2):498-504. doi: 10.1111/cas.14777. Epub 2020 Dec 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.

N Engl J Med. 1969 Nov 6;281(19):1028-34. doi: 10.1056/NEJM196911062811902.

Clinical experience with L-asparaginase.

Recent Results Cancer Res. 1970;33:236-43. doi: 10.1007/978-3-642-99984-0_28.

Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.

J Pediatr. 1970 Sep;77(3):474-83. doi: 10.1016/s0022-3476(70)80023-3.

[Asparaginase, leukemia and cancer].

Bull Cancer. 1969 Oct-Dec;56(4):365-74.

Clinical experience with L-asparaginase.

Recent Results Cancer Res. 1970;33:257-62. doi: 10.1007/978-3-642-99984-0_30.

The clinical toxicities of L-asparaginase in treatment of leukemia and lymphoma.

Pediatrics. 1970 Apr;45(4):555-9.

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.

Cancer. 1970 Feb;25(2):279-305. doi: 10.1002/1097-0142(197002)25:2<279::aid-cncr2820250205>3.0.co;2-7.

Treatment of acute leukemia with L-asparaginase.

Recent Results Cancer Res. 1970;33:204-18. doi: 10.1007/978-3-642-99984-0_26.

Some clinical observations on the treatment with L-asparaginase of the acute leukemias.

Recent Results Cancer Res. 1970;33:296-315. doi: 10.1007/978-3-642-99984-0_34.

Adverse reactions of L-asparaginase.

Am J Pediatr Hematol Oncol. 1982 Fall;4(3):335-9.

引用本文的文献

Repurposing Asparaginase Therapy to Target Cisplatin-Resistant Cancer Cells.

Fundam Clin Pharmacol. 2025 Oct;39(5):e70044. doi: 10.1111/fcp.70044.

Exploring the potential of asparagine restriction in solid cancer treatment: recent discoveries, therapeutic implications, and challenges.

Med Oncol. 2024 Jun 15;41(7):176. doi: 10.1007/s12032-024-02424-3.

Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia.

Cancer Cell. 2024 Apr 8;42(4):552-567.e6. doi: 10.1016/j.ccell.2024.03.003.

Recent advances in glucose oxidase-based nanocarriers for tumor targeting therapy.

Heliyon. 2023 Sep 25;9(10):e20407. doi: 10.1016/j.heliyon.2023.e20407. eCollection 2023 Oct.

Amino acid metabolism in health and disease.

Signal Transduct Target Ther. 2023 Sep 13;8(1):345. doi: 10.1038/s41392-023-01569-3.

Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunity.

Blood. 2023 May 25;141(21):2553-2565. doi: 10.1182/blood.2022018258.

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy.

Blood Lymphat Cancer. 2022 May 30;12:55-79. doi: 10.2147/BLCTT.S342052. eCollection 2022.

The past, present, and future of enzyme-based therapies.

Drug Discov Today. 2022 Jan;27(1):117-133. doi: 10.1016/j.drudis.2021.09.004. Epub 2021 Sep 16.

Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.

Paediatr Drugs. 2021 Sep;23(5):457-463. doi: 10.1007/s40272-021-00463-1. Epub 2021 Aug 5.

Dietary intervention as a therapeutic for cancer.

Cancer Sci. 2021 Feb;112(2):498-504. doi: 10.1111/cas.14777. Epub 2020 Dec 31.